title: [Experience with new vaccines in rabies vaccination treatment (author's transl)].
abstract: As a result of our experience in 266 persons vaccinated with HDC vaccine we consider this type of vaccine to be a great advance. In spite of our very positive judgement we are of the opinion that vaccination should not be done without adequate indication. This type of vaccine contains certain imponderables which argue against widespread vaccination. At any rate, complications occurred in one of our patients vaccinated with HDC vaccine Mérieux. Nevertheless we consider vaccination before exposure of persons who are genuinely at risk, such as veterinarians, laboratory staff in rabies laboratories and possibly also hunters and agriculturalists in infected areas to be acceptable.
mesh_terms: D000818:Animals; D000835:Animals, Wild; D004199:Disease Vectors; D004341:Drug Evaluation; D006801:Humans; D011818:Rabies / Q000517:prevention & control*; D011819:Rabies Vaccines / Q000592:standards*
chemical_list: D011819:Rabies Vaccines
vernacular_title: Erfahrungen mit neuen Impfstoffen bei der Wutschutzbehandlung.